Verrieres le Buisson, France

Armand Frydman


Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Maisons Alfort, FR (2003)
  • Verrieres le Buisson, FR (2003 - 2004)

Company Filing History:


Years Active: 2003-2004

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Armand Frydman: Innovator in Pharmaceutical Chemistry

Introduction

Armand Frydman is a notable inventor based in Verrieres le Buisson, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 4 patents, Frydman's work focuses on innovative solutions for cancer treatment.

Latest Patents

Frydman's latest patents include "Phenanthroline-7-one derivatives and their therapeutic uses." This patent describes a pharmaceutical composition that includes an efficient amount of a compound selected among specific formulae. The compounds exhibit interesting cytotoxic properties, leading to their potential use as antitumoral medicines. Another significant patent is "Pharmaceutical compositions comprising 4-quinolones for treating cancers." This composition is non-cytotoxic and acts on the proliferation of clonogenic cells in malignant tumors, also including an efficient amount of a compound selected among designated formulae.

Career Highlights

Throughout his career, Frydman has worked with reputable organizations, including Laboratoire L. Lafon. His innovative research has contributed to advancements in cancer therapies, showcasing his commitment to improving patient outcomes through scientific discovery.

Collaborations

Frydman has collaborated with esteemed colleagues such as Francis Darro and Robert Kiss. These partnerships have further enriched his research and development efforts in the pharmaceutical field.

Conclusion

Armand Frydman stands out as a dedicated inventor whose work in pharmaceutical chemistry has the potential to make a significant impact on cancer treatment. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…